C-AD Accelerator Physics Seminar
"Research on Alpha Emitters"
Presented by Dr. Ekaterina Dadachova, College of Medicine, Yeshiva University, NY
Monday, October 7, 2013, 3:30 pm
Bldg 911B, Large Conf. Rm., Rm A202
"Alpha-emitters have been investigated for targeted therapy of cancer for several decades and some of the alpha-emitter based radiopharmaceuticals have been approved by FDA for clinical use or are in advanced stage clinical trials. In our laboratory we are investigating radioimmunotherapy of pancreatic cancer with 213Bismuth labeled antibodies to single stranded DNA. We have pioneered the use of alpha-emitters for radioimmunotherapy of infectious diseases including fungal, bacterial and viral (HIV) infections. Targeted alpha therapy is an effective and safe treatment modality for both cancer and infectious diseases."